Diabetic cardiomyopathy is a distinct pathology independent of co-morbidities such as
coronary artery disease and hypertension. Diminished glucose uptake due to impaired …

Lipotoxicity cardiomyopathy is the result of excessive accumulation and oxidation of toxic
lipids in the heart. It is a major threat to patients with diabetes. Glucagon‐like peptide‐1 …

The incidence of cardiovascular disorders is one of the most concerns among people who
underwent cancer therapy. The heart side effects of cancer therapy may occur during …

Recent evidence indicates that toll-like receptor (TLR) 2 and 4 are involved in the
pathogenesis of dilated cardiomyopathy (DCM), but the exact mechanisms of their actions …

Rationale: We previously showed that transgenic mice expressing Ca2+/calmodulin-
dependent protein kinase II δC (CaMKII-TG) develop dilated cardiomyopathy associated …

Excessive death of cardiac myocytes leads to many cardiac diseases, including myocardial
infarction, arrhythmia, heart failure and sudden cardiac death. For the last several decades …

MicroRNAs (miRNAs) are small non-coding RNAs that act as post-transcriptional gene
regulators. They are involved in the pathogenesis of different disorders including heart …

BACKGROUND: 3′, 5′-cyclic AMP (cAMP) regulates numerous cardiac functions. Various
hormones and neurotransmitters elevate intracellular cAMP (i [cAMP]) in cardiomyocytes …

Dilated cardiomyopathy (DCM) represents the final common morphofunctional pathway of
various pathological conditions in which a combination of myocyte injury and necrosis …

Cardiovascular disease (CVD) is the leading cause of death throughout the world. The
increase in new patients every year leads to a demand for the identification of valid and …